Burning Rock Biotech (BNR) Preferred Stock Liabilities (2019 - 2020)

Burning Rock Biotech's Preferred Stock Liabilities history runs 1 years deep, the most recent figure standing at $216.7 million for Q4 2019.

• In Q4 2019, Preferred Stock Liabilities changed N/A year-over-year to $216.7 million; the TTM figure through Dec 2019 stood at $216.7 million (changed N/A YoY), while the FY2019 annual figure was $221.2 million, changed N/A from the prior year.
• Preferred Stock Liabilities for Q4 2019 stood at $216.7 million.
• The five-year high for Preferred Stock Liabilities was $216.7 million in Q4 2019, with the low at $216.7 million in Q4 2019.